Alcoholism treatment before, after liver transplantation reduces relapseScience CodexA second study determines that continued alcohol abuse following liver transplantation decreases graft survival, further highlighting the importance of preventing alco…
Alcoholism treatment before, after liver transplantation reduces relapseEurekAlert (press release)New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relap…
Alcoholism treatment before, after liver transplantation reduces relapseMedical XpressNew research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates tha…
Alcoholism Treatment Before, After Liver Transplantation Reduces RelapseThe AlmagestNew research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than …
World Congress on Islet/Pancreas Transplantation Shows U.S. Losing GroundEON: Enhanced Online News (press release)MONTEREY, Calif.–(EON: Enhanced Online News)–World transplant and diabetes leaders convened in Monterey at the International Pancreas an…
|
Saint Luke’s liver transplantation program receives CMS certification
News-Medical.net The liver transplantation program at Saint Luke’s Hospital of Kansas City has received certification by the Centers for Medicare and Medicaid (CMS). The certification is an important step in enhancing the hospital’s ability to care for Medicare-covered … Saint Luke’s achieves liver transplantation CMS certificationDigitalJournal.com |
|
Saint Luke’s achieves liver transplantation CMS certification
DigitalJournal.com KANSAS CITY, Mo., Oct. 2, 2013 /PRNewswire-USNewswire/ — The liver transplantation program at Saint Luke’s Hospital of Kansas City has received certification by the Centers for Medicare and Medicaid (CMS). The certification is an important step in … |
Siliconrepublic.com |
Opsona Therapeutics Limited raises an additional ?3 million (US $4 million …
4-traders (press release) Dr. Bruno Montanari, Life Sciences Director, Omnes Capital, added: “I am looking forward to progressing Opsona’s lead product OPN-305 through the well-designed Phase II efficacy study to prevent delayed graft function (DGF) in renal transplantation, an … Opsona Therapeutics raises €3m (US$4m) in Series C extension roundSiliconrepublic.com |
|
New leadership announced within Michael E. DeBakey department of surgery
BCM News … assistant professor of surgery, has been appointed section chief of renal transplantation. She is also surgical director of kidney transplantation at Texas Children’s Hospital, surgical director of kidney transplant at St. Luke’s Medical Center and … |
|
World Congress on Islet/Pancreas Transplantation Shows US Losing Ground
The Herald | HeraldOnline.com MONTEREY, Calif. — World transplant and diabetes leaders convened in Monterey at the International Pancreas and Islet Transplantation Association (IPITA) to discuss advances in islet and pancreas transplantation as superior therapies for treating type … |